Cargando…
Management of hypertension and dyslipidemia in Mexico: evidence, gaps, and approach
Hypertension and dyslipidemia are key risk factors for cardiovascular disorders and mortality worldwide. To understand the local health system challenges faced in the management of the two conditions, a semi-systematic approach was adopted for quantifying stages of the journey of care of adult Mexic...
Autores principales: | Morales-Villegas, Enrique C., Yarleque, Carlos, Almeida, María L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Permanyer Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161831/ https://www.ncbi.nlm.nih.gov/pubmed/35359036 http://dx.doi.org/10.24875/ACM.21000330 |
Ejemplares similares
-
Patient journey for hypertension and dyslipidemia in Saudi Arabia: highlighting the evidence gaps
por: Amir, Ashraf, et al.
Publicado: (2023) -
Challenges faced by patients with dyslipidemia and systemic arterial hypertension in Brazil: a design of the patient journey
por: Faria-Neto, Jose Rocha, et al.
Publicado: (2022) -
Hypertension and Dyslipidemia Combined Therapeutic Approaches
por: Borghi, Claudio, et al.
Publicado: (2022) -
A semi-systematic review on hypertension and dyslipidemia care in Egypt—highlighting evidence gaps and recommendations for better patient outcomes
por: Reda, Ashraf, et al.
Publicado: (2021) -
Hypertension and Dyslipidaemia in Argentina: Patient Journey Stages
por: Sadler, Alberto E, et al.
Publicado: (2022)